News & Perspective

Until COVID, TB was the world's top infectious cause of death, and the pandemic threatens to derail efforts to curtail it.

Tuberculosis notifications in the hard-hit countries of India, Indonesia, and the Philippines have fallen 25% to 30% because of pandemic-related disruptions.

Russia's vaccine hasn't been through phase 3 trials, raising worries that the country is skipping key safety steps.

A long-standing practice of using antibiotics to test for TB is unreliable for diagnosing the disease.

A modest lockdown could add 1.8 million TB cases and 342,000 deaths globally over 5 years.

The WHO urges nations to maintain continuity of TB services as they respond to COVID-19.

Global funding has reached an all-time high but falls far short of what's needed to eliminate TB.

The vaccine demonstrated 49.7% protection against progression to active tuberculosis in adults.

Of 10 million people estimated to have TB in 2018, 7 million were diagnosed, meeting a recent UN goal.

The shorter, simpler regimen with the new drug is poised to improve treatment against a difficult disease and to lower costs.